Stay updated on Nivolumab vs Dacarbazine in Melanoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Added Tel Litwinsky, Israel, 52621 to the Locations section and removed Qiryat Krinitzi, Israel, 52621 from it. Melanoma and related topics, including MedlinePlus Genetics, were removed from the page.
    Difference
    0.1%
    Check dated 2026-09-12T18:31:05.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    Tel Litwinsky, Israel, 52621 was removed and Qiryat Krinitzi, Israel, 52621 was added to the study locations. Melanoma and MedlinePlus Genetics were added as related topics.
    Difference
    0.1%
    Check dated 2026-09-05T20:35:32.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.5 to v3.6.6, signaling a newer version of the page content.
    Difference
    0.0%
    Check dated 2026-08-29T20:02:46.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Melanoma has been removed from the related topics section. The MedlinePlus Genetics link under related topics is also removed, and the related topics header is no longer displayed.
    Difference
    0.1%
    Check dated 2026-08-22T21:43:39.000Z thumbnail image
  5. Check
    31 days ago
    Change Detected
    Summary
    Footer/navigation blocks including BMS branding and sections such as 'BMS Clinical Trial Information' and 'BMS Clinical Trial Patient Recruiting' were added, along with related help links. Expanded MeSH term metadata and related topics were also included to enrich context and discoverability of the study.
    Difference
    82%
    Check dated 2026-08-15T20:49:52.000Z thumbnail image
  6. Check
    38 days ago
    Change Detected
    Summary
    The page’s revision tag was updated from v3.6.4 to v3.6.5, indicating a minor system or content update. This does not modify the study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-08-08T18:29:07.000Z thumbnail image

Stay in the know with updates to Nivolumab vs Dacarbazine in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab vs Dacarbazine in Melanoma Clinical Trial page.